Advertisement

Mobile Banner
Mobile Banner
Mobile Banner
Loading...

Trinity Biotech plc

TRIB•NASDAQ
Healthcare
Medical - Diagnostics & Research
$0.74
$0.03(4.38%)
U.S. Market opens in 17h 12m

Trinity Biotech plc (TRIB) Stock Overview

Explore Trinity Biotech plc’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap7.3M
P/E Ratio-0.37
EPS (TTM)$-1.60
ROE0.81%
Fundamental Analysis

AI Price Forecasts

1 Month$0.77
3 Months$0.84
1 Year Target$0.00

TRIB Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Trinity Biotech plc (TRIB) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 40.49, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $0.00.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -0.37 and a market capitalization of 7.3M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-1.56%
5-Day Change
-9.57%
1-Month Change
-22.54%
3-Month Change
-15.56%
6-Month Change
-91.07%
Year-to-Date (YTD) Change
-6.06%
1-Year Change
-82.90%
3-Year Change
-97.43%
5-Year Change
-99.49%
All-Time (Max) Change
-99.82%

Contact Information

https://www.trinitybiotech.com
353 1 276 9800
IDA Business Park, Bray, NaN, A98 H5C8

Company Facts

3,800 Employees
IPO DateOct 21, 1992
CountryIE
Actively Trading

Frequently Asked Questions